The Latest Breaking News from FDA

The FDA is holding potential Sanfilippo syndrome therapies to an impossible and inhumane standard

Two sleep doctors answer everything you need to know about melatonin gummies, including the side effects, how long they last and how many you should take.

Modern medical devices are lifesavers. But they’re vulnerable to hackers and compromise our privacy.

With no shortage of major releases on the docket, 2024 is likely to be an exciting year in the world of smartwatches.

Find out about a review by the FDA supporting the reclassification of marijuana as a Schedule 3 substance due to its lower abuse potential and accepted med...

The pharmaceutical sector is anticipated to prosper due to the strong demand for drugs and therapies and the adoption of advanced technologies. So, let’s analyze whether pharmaceutical stocks Kamada (KMDA), Neurocrine Biosciences (NBIX), and Novartis (NVS) are well positioned to capitalize on the industry’s growth prospects.

Learn about the recent recall of ResMed's respiratory devices by the US FDA, deemed as the most serious. Find out more about the implications and what acti...

The FDA states that popular drugs for diabetes and obesity do not appear to be linked to suicidal thoughts but continues to investigate reports.

Federal officials say a preliminary review finds no connection between suicidal thoughts and a new class of diabetes and obesity drugs